[go: up one dir, main page]

ATE207922T1 - Carbapenem-derivate - Google Patents

Carbapenem-derivate

Info

Publication number
ATE207922T1
ATE207922T1 AT95909978T AT95909978T ATE207922T1 AT E207922 T1 ATE207922 T1 AT E207922T1 AT 95909978 T AT95909978 T AT 95909978T AT 95909978 T AT95909978 T AT 95909978T AT E207922 T1 ATE207922 T1 AT E207922T1
Authority
AT
Austria
Prior art keywords
group
substituted
lower alkyl
alkyl group
single bond
Prior art date
Application number
AT95909978T
Other languages
English (en)
Inventor
Susumu Nakagawa
Hiroshi Fukatsu
Ryosuke Ushijima
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Application granted granted Critical
Publication of ATE207922T1 publication Critical patent/ATE207922T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT95909978T 1994-02-25 1995-02-24 Carbapenem-derivate ATE207922T1 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP5268694 1994-02-25
JP6460694 1994-03-08
JP10756894 1994-04-22
JP11028994 1994-04-26
JP11428894 1994-04-28
PCT/JP1995/000280 WO1995023150A1 (fr) 1994-02-25 1995-02-24 Derive de carbapendem

Publications (1)

Publication Number Publication Date
ATE207922T1 true ATE207922T1 (de) 2001-11-15

Family

ID=27523026

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95909978T ATE207922T1 (de) 1994-02-25 1995-02-24 Carbapenem-derivate

Country Status (8)

Country Link
US (1) US5707987A (de)
EP (1) EP0747381B1 (de)
JP (1) JP4182545B2 (de)
AT (1) ATE207922T1 (de)
AU (1) AU680736B2 (de)
CA (1) CA2184101C (de)
DE (1) DE69523574T2 (de)
WO (1) WO1995023150A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2315056A1 (en) * 1997-12-16 1999-06-24 Terutaka Hashizume Carbapenem derivatives
CA2415740A1 (en) 2000-07-19 2002-01-31 F. Hoffmann-La Roche Ag Pyrrolidine derivatives as metalloprotease inhibitors
JP3813152B2 (ja) * 2002-03-12 2006-08-23 メルク エンド カムパニー インコーポレーテッド 置換アミド類
TWI281914B (en) 2002-05-29 2007-06-01 Glaxo Group Ltd Compounds
ATE479683T1 (de) 2002-11-05 2010-09-15 Glaxo Group Ltd Antibakterielle mittel
DK2666481T3 (en) 2003-12-26 2019-02-25 Masatoshi Hagiwara A method for regulating the phosphorylation of SR protein and antiviral agents comprising an SR protein activity regulator as the active ingredient
US20070149607A1 (en) * 2003-12-26 2007-06-28 Daichi Paharmaceutical Co., Ltd. Method for producing pyrrolidine derivative
KR100599876B1 (ko) * 2004-08-31 2006-07-13 한국화학연구원 2-아릴메틸아제티딘 카바페넴 유도체 및 그의 제조방법
WO2006045096A2 (en) * 2004-10-20 2006-04-27 Resverlogix Corp. Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
AU2006275514B2 (en) * 2005-07-29 2012-04-05 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
TW200831084A (en) * 2006-11-21 2008-08-01 Genelabs Tech Inc Anti-viral compounds
ES2454966T3 (es) * 2007-02-01 2014-04-14 Resverlogix Corp. Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares
CN101343272B (zh) * 2007-07-13 2011-02-09 山东轩竹医药科技有限公司 含有环己烷的碳青霉烯化合物
CN101412720B (zh) * 2007-08-27 2011-05-18 山东轩竹医药科技有限公司 含有巯基氮杂环乙烯基的碳青霉烯化合物
SI2346837T1 (sl) 2008-06-26 2015-05-29 Resverlogix Corporation Postopki pripravljanja kinazolinonskih derivatov
JP5635535B2 (ja) 2009-01-08 2014-12-03 レスバーロジックス コーポレイション 心血管疾患の予防および治療のための化合物
NZ755378A (en) 2009-03-18 2022-07-29 Resverlogix Corp Novel quinazolinones and related compounds for use as anti-inflammatory agents
ES2821018T3 (es) 2009-04-22 2021-04-23 Resverlogix Corp Nuevos agentes antiinflamatorios
US9610251B2 (en) 2011-11-01 2017-04-04 Resverlogix Corp. Pharmaceutical compositions for substituted quinazolinones
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
WO2014080290A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Cyclic amines as bromodomain inhibitors
KR20150096794A (ko) 2012-12-21 2015-08-25 제니쓰 에피제네틱스 코포레이션 브로모도메인 저해제로서의 신규한 헤테로사이클릭 화합물
JO3789B1 (ar) 2015-03-13 2021-01-31 Resverlogix Corp التراكيب والوسائل العلاجية المعتمدة لمعالجة الامراض المتعلقة بالمتممة

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62155279A (ja) * 1984-11-08 1987-07-10 Sumitomo Pharmaceut Co Ltd 新規なβ−ラクタム化合物
JPH0780883B2 (ja) * 1986-03-27 1995-08-30 住友製薬株式会社 新規なβ−ラクタム化合物
DE3784147T2 (de) * 1986-11-24 1993-06-03 Fujisawa Pharmaceutical Co 3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-en-2-carbonsaeure-derivate.
US4925838A (en) * 1988-03-18 1990-05-15 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
US4963544A (en) * 1988-05-23 1990-10-16 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
DE68916908T2 (de) * 1988-11-08 1994-12-01 Daiichi Seiyaku Co Carbapenemderivate.
CA2091309A1 (en) * 1992-03-26 1993-09-27 Frederic H. Jung Antibiotic compounds

Also Published As

Publication number Publication date
AU1824095A (en) 1995-09-11
DE69523574D1 (de) 2001-12-06
AU680736B2 (en) 1997-08-07
DE69523574T2 (de) 2002-05-29
JP4182545B2 (ja) 2008-11-19
CA2184101C (en) 2005-11-22
EP0747381A4 (de) 1997-04-02
CA2184101A1 (en) 1995-08-31
US5707987A (en) 1998-01-13
WO1995023150A1 (fr) 1995-08-31
EP0747381B1 (de) 2001-10-31
EP0747381A1 (de) 1996-12-11

Similar Documents

Publication Publication Date Title
DE69523574D1 (de) Carbapenem-derivate
IL107426A0 (en) Heterocyclic compounds, processes for the preparation thereof, and pharmaceutical compositions containing the same
CA2311742A1 (en) 6-amino-9-benzyl-8-hydroxypurine derivatives
ES8802023A1 (es) Procedimiento para la obtencion de amidas de acidos benzoheterociclilalcanoicos
CA2039056A1 (en) 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
DK0736018T3 (da) 4,5-Diaryloxazolderivater
AU6052594A (en) New heterocyclic compounds
WO2000075113A8 (fr) Nouveaux derives carboxamide heterocycliques
ATE78470T1 (de) Imidazolin-derivate und verfahren zu deren herstellung.
CA2047347A1 (en) Thioalkylthio cephalosporins derivatives
DE3381734D1 (de) Thiazolylessigsaeure-derivate und verfahren zu deren herstellung.
AU8226891A (en) Benzopyran derivative, production thereof, and pharmaceutical composition containing the same
AU671163B2 (en) Alkyl substituted heterocyclic compounds
IE56917B1 (en) N-sulphenylated hydantoins,a process for their preparation and their use as microbicides
ZA939604B (en) Imidazole derivatives
EP0903346A4 (de)
JPS55167206A (en) Industrial bactericidal and fungicidal agent
AU7506591A (en) A therapeutic agent for dysuria comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives
GR3015002T3 (en) 1,4-Dihydro-4-oxo-3-quinolone derivatives as selectively toxic mammalian antibacterial agents.
EP0652220A4 (de) Cephalosporin-derivate.
ES8506585A1 (es) Un procedimiento para la obtencion de sales de amonio cuaternarias

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties